Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection

C Papavassilis1, K K Mach, P A Mayser

  • 1Department of Dermatology and Andrology, Justus Liebig University, Giessen, Germany. charis.papavassilis@derma.med.uni-giessen.de

Critical Care Medicine
|October 3, 1999
PubMed
Abstract

Insights

Certain Malassezia species can grow on lipid infusions, but medium-chain triglycerides and free fatty acids inhibit their growth. These findings suggest using lipid infusions with medium-chain triglycerides to prevent Malassezia infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Lipophilic Malassezia species are associated with catheter-associated sepsis, particularly in neonates and immunocompromised individuals receiving parenteral nutrition.
  • Parenteral lipid emulsions are a potential nutrient source for Malassezia species, raising concerns about infection risk.

Purpose of the Study:

  • To investigate the ability of various Malassezia species to utilize commercially available lipid infusions as a sole lipid source.
  • To evaluate the impact of medium-chain triglycerides (MCTs) and medium-chain free fatty acids (MCFFAs) on Malassezia growth in lipid emulsions.

Main Methods:

  • Prospective in vitro study conducted in a university hospital research laboratory.
  • Testing of seven Malassezia species, including M. furfur, for growth on different commercially available lipid infusions.
  • Assessment of growth inhibition using varying concentrations of MCTs and MCFFAs.

Main Results:

  • All tested Malassezia species, except M. restricta, demonstrated growth on lipid infusions, with no significant brand-specific differences.
  • M. furfur exhibited the most rapid growth, with enhanced proliferation at 20% lipid concentration compared to 10%.
  • Growth of M. furfur and M. sympodialis was significantly reduced by the presence of MCTs, with further suppression by MCFFAs.

Conclusions:

  • Medium-chain triglycerides and medium-chain free fatty acids exhibit toxicity towards Malassezia species.
  • Commercially available lipid infusions containing MCTs show potential as a preventative strategy against systemic Malassezia infections.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The Skin Microbiota01:27

The Skin Microbiota

The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...